See the DrugPatentWatch profile for ozempic

Ozempic, also known as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to regulate daily glucose levels in adults with type 2 diabetes. It mimics the functions of natural GLP-1 hormones in the body, which are responsible for regulating blood sugar levels and promoting insulin secretion [1].

Ozempic works by increasing insulin secretion in response to elevated blood glucose levels, thereby reducing the amount of glucose in the blood [2]. It also decreases glucagon secretion, which is a hormone that increases blood sugar levels. Additionally, Ozempic slows down gastric emptying, leading to a more gradual absorption of glucose into the bloodstream [3].

Furthermore, Ozempic has been shown to promote weight loss, which can help improve insulin sensitivity and reduce the risk of complications associated with type 2 diabetes [4].

In summary, Ozempic regulates daily glucose levels by increasing insulin secretion, decreasing glucagon secretion, slowing down gastric emptying, and promoting weight loss.

Sources:

1. "Ozempic (semaglutide) injection, for subcutaneous use." DailyMed, <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5a8d2a5f-8e5e-4e1e-aebd-6f8b9d6d6e3a&type=display>.
2. "Semaglutide." DrugPatentWatch, <https://www.drugpatentwatch.com/drugs/semaglutide>.
3. "How Ozempic Works." Novo Nordisk, <https://www.ozempic.com/how-ozempic-works>.
4. "Ozempic (semaglutide) for type 2 diabetes." Mayo Clinic, <https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/in-depth/ozempic/art-20473151>.